Diabetic Foot Care Programs
Practices specializing in diabetic wound care, neuropathy management, and limb preservation.
Market snapshot
These figures describe Podiatry (4.10.22), the segment that Diabetic Foot Care Programs sits within — not Diabetic Foot Care Programs on its own.
- Market size
- ~$5.4B
- Growth
- ~3.0%CAGR (2017–22, nominal)
- Companies
- ~7,600
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 621391 (Offices of Podiatrists).
Business model & economics
Revenue model
Visit and procedure reimbursement plus ancillaries
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 15–25%
- Capex intensity
- Low
recurring diabetic and chronic foot care
Characteristics
- Aging and diabetes prevalence drive demand.
- Ancillaries and diabetic-care programs enhance economics.
- Emerging MSO/PE consolidation.
Geographic concentration
Podiatry practices concentrate in the dense Northeast corridor — New Jersey, New York, Pennsylvania, and Connecticut — tracking population age and physician density.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 621391. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Podiatry MSO platforms
- PE-backed consolidators
- Multispecialty groups
What’s driving deals
- Emerging podiatry roll-up.
- Diabetes and aging-driven demand.
- Ancillary-driven economics.
Find Diabetic Foot Care Programs acquisition targets
Search Acquisera’s index for companies classified under Diabetic Foot Care Programs (4.10.22.1) and build a targeted deal pipeline.
Search companies